ApoA1 can suppress hepatocellular carcinoma (HCC) by promoting cell cycle arrest and enhancing tumor cell apoptosis via inactivating the mitogen-activated protein kinase (MAPK) signaling pathway. This evidence concerns the gene WNK2 and hepatocellular carcinoma.